col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Oxford University Press: The Journal of Infectious Diseases
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―30 Editorial: COVID-19 severity in obese patients may be linked to viral load and immune response Alexander M Lewis, Xinya Zhang, Jonathan R  Brestoff
2 [GO] 2021―Jul―30 Clinical, immunological and virological SARS-CoV-2 phenotypes in obese and non-obese military health system beneficiaries Nusrat J Epsi, Stephanie A Richard, Eric D Laing, Anthony C Fries, Eugene Millar, Mark P Simons, et al. (+17)
3 [GO] 2021―Jul―29 SARS-CoV-2 normalized viral loads and subgenomic RNA detection as tools for improving clinical decision-making and work reincorporation Marta Santos Bravo, David Nicolás, Carla Berengua, Mariana Fernandez, Juan Carlos Hurtado, Marta Tortajada, et al. (+5)
4 [GO] 2021―Jul―28 The LGBTQ+ communities and the COVID-19 pandemic: a call to break the cycle of structural barriers Raul Macias Gil, Tracey Freeman, Trini Mathew, Ravina Kullar, Anais Ovalle, Don Nguyen, et al. (+4)
5 [GO] 2021―Jul―22 Higher viral load drives infrequent SARS-CoV-2 transmission between asymptomatic residence hall roommates Kristen K Bjorkman, Tassa K Saldi, Erika Lasda, Leisha Conners Bauer, Jennifer Kovarik, Patrick K Gonzales, et al. (+10)
6 [GO] 2021―Jul―21 Inter-subject variation in ACE2 protein expression in human airway epithelia and its relationship to SARS-CoV-2 infection Kun Li, Christine Wohlford-Lenane, Jennifer A Bartlett, Paul B McCray
7 [GO] 2021―Jul―19 Kinetics of the SARS-CoV-2 antibody response and serological estimation of time since infection Stéphane Pelleau, Tom Woudenberg, Jason Rosado, Françoise Donnadieu, Laura Garcia, Thomas Obadia, et al. (+37)
8 [GO] 2021―Jul―17 Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab among High-Risk Patients with Mild to Moderate Coronavirus Disease 2019 Ravindra Ganesh, Lindsey M Philpot, Dennis M Bierle, Ryan J Anderson, Lori L Arndt, Richard F Arndt, et al. (+13)
9 [GO] 2021―Jul―16 Not All Monoclonal Antibodies for COVID-19 Are Created Equal Valentina Stosor, Michael P Angarone
10 [GO] 2021―Jul―13 SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion Isabella Ferreira, Steven Kemp, Rawlings Datir, Akatsuki Saito, Bo Meng, Partha Rakshit, et al. (+11)
11 [GO] 2021―Jul―12 Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing Jennifer A Rathe, Emily A Hemann, Julie Eggenberger, Zhaoqi Li, Megan L Knoll, Caleb Stokes, et al. (+5)
12 [GO] 2021―Jul―12 Cross-sectional assessment of SARS-CoV-2 viral load by symptom status in Massachusetts congregate living facilities Niall J Lennon, Roby P Bhattacharyya, Michael J Mina, Heidi L Rehm, Deborah T Hung, Sandra Smole, et al. (+3)
13 [GO] 2021―Jul―08 Molnupiravir inhibits the replication of the emerging SARS-CoV-2 variants of concern (VoCs) in a hamster infection model Rana Abdelnabi, Caroline S Foo, Steven De Jonghe, Piet Maes, Birgit Weynand, Johan Neyts
14 [GO] 2021―Jul―02 Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing Talya Shragai, Sarah E Smith-Jeffcoat, Mitsuki Koh, Marcos C Schechter, Paulina A Rebolledo, Vyjayanti Kasinathan, et al. (+19)
15 [GO] 2021―Jul―02 Limited neutralization of authentic SARS-CoV-2 variants carrying E484K in vitro Marek Widera, Alexander Wilhelm, Sebastian Hoehl, Christiane Pallas, Niko Kohmer, Timo Wolf, et al. (+7)
16 [GO] 2021―Jun―30 Longitudinal Serological Analysis following National Seroprevalence Study to Investigate COVID-19 Infection in People Living in Ireland Andrew Beverland, Mary Keogan, Jeff Connell, Cillian De Gascun, Derval Igoe
17 [GO] 2021―Jun―29 Comment on: Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS Ming Tong, Qing Zheng, Fang Chen, Yimin Zhu
18 [GO] 2021―Jun―29 Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS Markus K Kristensen, Ronni R Plovsing, Ronan M G Berg, Rikke Krogh Madsen, Andreas Ronit
19 [GO] 2021―Jun―24 Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection Pyoeng Gyun Choe, Chang Kyung Kang, Kye-Hyung Kim, Jongyoun Yi, Eu Suk Kim, San Won Park, et al. (+3)
20 [GO] 2021―Jun―22 Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples Khalid Sharwani, Ravi Sharma, Madhan Krishnan, Terry Jones, Martin Mayora-Neto, Diego Cantoni, et al. (+7)
21 [GO] 2021―Jun―21 Accelerating the evolution of SARS-CoV-2 - a risk of combining dexamethasone and tocilizumab for severe COVID-19 David Koeckerling, Joseph Barker
22 [GO] 2021―Jun―19 Early Convalescent Plasma Therapy and Mortality among US Veterans Hospitalized with Non-Severe COVID-19: An Observational Analysis Emulating a Target Trial Kelly Cho, Sarah C Keithly, Katherine E Kurgansky, Arin L Madenci, Hanna Gerlovin, Helen M Wellman, et al. (+18)
23 [GO] 2021―Jun―16 Large-scale identification of T cell epitopes derived from SARS-CoV-2 for the development of peptide vaccines against COVID-19 Yipeng Ma, Fenglan Liu, Tong Lin, Lei Chen, Aixin Jiang, Geng Tian, et al. (+2)
24 [GO] 2021―Jun―15 Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City Sarah L Braunstein, Jennifer Sanderson Slutsker, Rachael Lazar, Dipal Shah, Robin R Hennessy, Shirley Chen, et al. (+3)
25 [GO] 2021―Jun―09 COVID-19 mRNA vaccination generates greater IgG levels in women compared to men Alexis R Demonbreun, Amelia Sancilio, Matt E Velez, Daniel T Ryan, Lorenzo Pesce, Rana Saber, et al. (+7)
26 [GO] 2021―Jun―07 Proper assignation of reactivation in a COVID-19 recurrence initially interpreted as a reinfection Laura Pérez Lago, Helena Martínez Lozano, Jose Antonio Pajares Díaz, Arantxa Díaz Gómez, Marina Machado, Pedro J Sola-Campoy, et al. (+11)
27 [GO] 2021―Jun―04 Marked increase in avidity of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) antibodies 7-8 months after infection is not diminished in old age Daniel Pichler, Matthias Baumgartner, Janine Kimpel, Annika Rössler, Lydia Riepler, Katie Bates, et al. (+4)
28 [GO] 2021―Jun―04 Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection Valeria De Giorgi, Kamille A West, Amanda N Henning, Leonard N Chen, Michael R Holbrook, Robin Gross, et al. (+7)
29 [GO] 2021―Jun―04 A multiregional evaluation of Ct values in SARS-CoV-2 VOC-20DEC-01 variant K J Hill, R Dewar, K Templeton
30 [GO] 2021―Jun―03 Accounting for imported cases in estimating the time-varying reproductive number of COVID-19 in Hong Kong Tim K Tsang, Peng Wu, Eric H Y Lau, Benjamin J Cowling
31 [GO] 2021―Jun―03 Clarification regarding Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review Nooshin Razani, Mohsen Malekinejad, George W Rutherford
32 [GO] 2021―Jun―03 Prevalence of SARS-CoV-2 antibodies in New York City adults, June-October, 2020: a population-based survey Jannae C Parrott, Ariana N Maleki, Valerie E Vassor, Sukhminder Osahan, Yusyin Hsin, Michael Sanderson, et al. (+9)
33 [GO] 2021―May―31 Corrigendum to: Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results Natalie N Kinloch, Gordon Ritchie, Chanson J Brumme, Winnie Dong, Weiyan Dong, Tanya Lawson, et al. (+8)
34 [GO] 2021―May―25 SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model Bart L Haagmans, Danny Noack, Nisreen M A Okba, Wentao Li, Chunyan Wang, Theo Bestebroer, et al. (+16)
35 [GO] 2021―May―06 Prolonged COVID-19 Disease in a Patient with Rheumatoid Arthritis on Rituximab Therapy Rachel Aviv, Andrew Weber, Tarif Anzum, Matthew Federbush, Diane Horowitz, Effie Singas
36 [GO] 2021―May―05 β-D-N 4-hydroxycytidine (NHC) Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells Shuntai Zhou, Collin S Hill, Sanjay Sarkar, Longping V Tse, Blaide M D Woodburn, Raymond F Schinazi, et al. (+4)
37 [GO] 2021―Apr―23 Activating Killer-cell Immunoglobulin-like Receptors are associated with the severity of COVID-19 Enrique Bernal, Lourdes Gimeno, María J Alcaraz, Ahmed A Q귮r, Marta Moreno, María V Martínez-Sánchez, et al. (+13)
38 [GO] 2021―Apr―20 Corrigendum to: Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine Licensure due to Ethical and Practical Issues Stanley M Spinola, Gregory D Zimet, Mary A Ott, Barry P Katz
39 [GO] 2021―Apr―06 A Silver Lining? Fewer non-SARS-CoV-2 Respiratory Viruses during the COVID-19 Pandemic Zachary M Most, Michael Holcomb, Andrew R Jamieson, Trish M Perl
40 [GO] 2021―Mar―23 Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): A comparison with influenza associated aspergillosis (IAPA) Frederic Lamoth, Russell E Lewis, Thomas J Walsh, Dimitrios P Kontoyiannis
41 [GO] 2021―Mar―20 Longitudinal Analysis of Human Memory T-Cell Response according to the Severity of Illness up to 8 Months after SARS-CoV-2 Infection Chang Kyung Kang, Minji Kim, Soojin Lee, Gwanghun Kim, Pyoeng Gyun Choe, Wan Beom Park, et al. (+8)
42 [GO] 2021―Mar―19 Anti-SARS-CoV2 antibody responses in serum and cerebrospinal fluid of COVID-19 patients with neurological symptoms Janet L Cunningham, Johan Virhammar, Bengt Rönnberg, Xaquin Castro Dopico, Linda Kolstad, Bo Albinsson, et al. (+9)
43 [GO] 2021―Mar―15 Rapidly Increasing SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced from Plasma Collected During the 2020 Pandemic Maria R Farcet, Michael Karbiener, Julia Schwaiger, Reinhard Ilk, Thomas R Kreil
44 [GO] 2021―Mar―13 Role of asymptomatic children in community SARS-CoV-2 transmission Liangjian Lu, Chee Teck Koh, Yi Herng Lim, Andrew Sng, Kok Siong Poon, Shaun S Y Tan, et al. (+5)
45 [GO] 2021―Mar―11 Comment on: Nature and Dimensions of the Systemic Hyper-Inflammation and its Attenuation by Convalescent Plasma in Severe COVID-19 Yeny Acosta-Ampudia, Manuel Rojas, Diana M Monsalve, Yhojan Rodríguez, Carolina Ramírez-Santana, Juan-Manuel Anaya
46 [GO] 2021―Mar―11 Complement Induced Endotheliopathy Associated Vascular Microthrombosis in Coronavirus 2019 Disease H Bradford Hawley, Jae C Chang
47 [GO] 2021―Mar―09 The Association of COVID-19 Risk Perception, County Death Rates, and Voluntary Health Behaviors among U.S. Adult Population Jad A Elharake, Mehr Shafiq, SarahAnn M McFadden, Amyn A Malik, Saad B Omer
48 [GO] 2021―Feb―18 Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats Linlin Bao, Zhiqi Song, Jing Xue, Hong Gao, Jiangning Liu, Jie Wang, et al. (+21)
49 [GO] 2021―Feb―16 The Cat’s in the Bag: Despite limited cat-to-cat SARS-CoV-2 transmission, One Health surveillance efforts are needed Meghan F Davis, Gabriel K Innes
50 [GO] 2021―Feb―12 Viral load of SARS-CoV-2 in adults during the first and second wave of COVID-19 pandemic in Houston, TX: the potential of the super-spreader Vasanthi Avadhanula, Erin G Nicholson, Laura Ferlic-Stark, Felipe-Andres Piedra, Brittani N Blunck, Sonia Fragoso, et al. (+9)
51 [GO] 2021―Feb―12 A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in COVID-19 patients with Regular Intravenous Immunoglobulin Therapy Raman R S, Vijaykumar Bhagwan Barge, Anil Kumar Darivenula, Himanshu Dandu, Rakesh R Kartha, Varun Bafna, et al. (+2)
52 [GO] 2021―Feb―11 High amounts of SARS-CoV-2 precede sickness among asymptomatic healthcare workers Joakim Dillner, K Miriam Elfström, Jonas Blomqvist, Lars Engstrand, Mathias Uhlén, Carina Eklund, et al. (+21)
53 [GO] 2021―Feb―03 UVB radiation alone may not explain sunlight inactivation of SARS-CoV-2 Paolo Luzzatto-Fegiz, Fernando Temprano-Coleto, François J Pea�rf, Julien R Landel, Yangying Zhu, Julie A McMurry
54 [GO] 2021―Jan―27 Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) Sumathi Sivapalasingam, George A Saviolakis, Kirsten Kulcsar, Aya Nakamura, Thomas Conrad, Mohamed Hassanein, et al. (+12)
55 [GO] 2021―Jan―25 Role of cell adhesion molecules for disease development of patients with and without COVID-19 in the emergency department Wolfgang Bauer, Jannis Ulke, Noa Galtung, Leonore Claudia Strasser-Marsik, Nick Neuwinger, Rudolf Tauber, et al. (+2)
56 [GO] 2021―Jan―23 Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis Asma Boumaza, Laetitia Gay, Soraya Mezouar, Eloïne Bestion, Aïssatou Bailo Diallo, Moise Michel, et al. (+7)
57 [GO] 2021―Jan―19 Immune profiling reveals early disease trajectories associated with COVID-19 mortality: a sub-study from the ACTT-1 trial Joshua M Thiede, Abigail R Gress, Samuel D Libby, Christine E Ronayne, William E Matchett, Brooke Noren, et al. (+5)
58 [GO] 2021―Jan―02 Tropism of SARS-CoV-2, SARS-CoV and influenza virus in canine tissue explants Christine H T Bui, H W Yeung, John C W Ho, Connie Y H Leung, Kenrie P Y Hui, Ranawaka A P M Perera, et al. (+5)
59 [GO] 2020―Dec―23 SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing Jennifer A Rathe, Emily A Hemann, Julie Eggenberger, Zhaoqi Li, Megan L Knoll, Caleb Stokes, et al. (+5)
60 [GO] 2020―Dec―21 Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic Jeffrey R Strich, Marcos J Ramos-Benitez, Davide Randazzo, Sydney R Stein, Ashley Babyak, Richard T Davey, et al. (+3)
61 [GO] 2020―Dec―14 Natural history of COVID-19: Risk factors for hospitalizations and deaths among >26 million U.S. Medicare beneficiaries Hector S Izurieta, David J Graham, Yixin Jiao, Mao Hu, Yun Lu, Yue Wu, et al. (+6)
62 [GO] 2020―Dec―03 Neutrophil more than platelet activation associates with thrombotic complications in COVID-19 patients E Petito, E Falcinelli, U Paliani, E Cesari, G Vaudo, M Sebastiano, et al. (+10)
63 [GO] 2020―Dec―02 SARS-CoV-2-induced immune activation and death of monocyte-derived human macrophages and dendritic cells Jian Zheng, Yuhang Wang, Kun Li, David K Meyerholz, Chantal Allamargot, Stanley Perlman
64 [GO] 2020―Nov―27 Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review Tommaso Celeste Bulfone, Mohsen Malekinejad, George W Rutherford, Nooshin Razani
65 [GO] 2020―Nov―17 Monocyte CD169 expression as a biomarker in the early diagnosis of COVID-19 Anne-Sophie Bedin, Alain Makinson, Marie-Christine Picot, Frank Mennechet, Fabrice Malergue, Amandine Pisoni, et al. (+14)
66 [GO] 2020―Nov―12 Corrigendum to: Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses Karoline Leuzinger, Tim Roloff, Rainer Gosert, Kirstin Sogaard, Klaudia Naegele, Katharina Rentsch, et al. (+12)
67 [GO] 2020―Nov―11 Long-term survival of SARS-CoV-2 on salmon as a source for international transmission Manman Dai, Huanan Li, Nan Yan, Jinyu Huang, Li Zhao, Siqi Xu, et al. (+4)
68 [GO] 2020―Nov―09 Corrigendum to: Clinical and Epidemiological Features of 46 Children <1 Year Old With Coronavirus Disease 2019 in Wuhan, China: A Descriptive Study Xinghua Liu, Jianqiao Tang, Rong Xie, Wei Li, Jianying Chen, Yan Guo, et al. (+8)
69 [GO] 2020―Nov―05 Possible auto-antigens that may explain the post-infection autoimmune manifestations in COVID-19 patients displaying neurological conditions Mugdha Mohkhedkar, Siva Sai Krishna Venigalla, Vani Janakiraman
70 [GO] 2020―Oct―28 On the effect of age on the transmission of SARS-CoV-2 in households, schools and the community E Goldstein, M Lipsitch, M Cevik
71 [GO] 2020―Oct―14 Independent side-by-side validation and comparison of four serological platforms for SARS-CoV-2 antibody testing Bernd Jahrsdörfer, Joris Kroschel, Carolin Ludwig, Victor Max Corman, Tatjana Schwarz, Sixten Körper, et al. (+8)
72 [GO] 2020―Oct―06 Rapid, sensitive and specific SARS coronavirus-2 detection: a multi-center comparison between standard qRT-PCR and CRISPR based DETECTR Eelke Brandsma, Han J M P Verhagen, Thijs J W van de Laar, Eric C J Claas, Marion Cornelissen, Emile van den Akker
73 [GO] 2020―Oct―06 Low incidence of reinfection with endemic coronaviruses diagnosed by RT-PCR Johan Ringlander, Staffan Nilsson, Johan Westin, Magnus Lindh, Anna Martner, Kristoffer Hellstrand
74 [GO] 2020―Oct―03 Upper respiratory tract levels of SARS-CoV-2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical COVID-19 Aylin Yilmaz, Emelie Marklund, Maria Andersson, Staffan Nilsson, Lars-Magnus Andersson, Magnus Lindh, Magnus Gisslén
75 [GO] 2020―Oct―03 Erratum to: Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2 Toni Luise Meister, Yannick Brüggemann, Daniel Todt, Carina Conzelmann, Janis A Müller, Rüdiger Groß, et al. (+6)
76 [GO] 2020―Oct―01 From Foe to Friend in COVID-19: RAS Inhibitors Jason Kidde, Amirhossein Sahebkar
77 [GO] 2020―Oct―01 Comparing Clinical Characteristics of Influenza and Common Coronavirus Infections using Electronic Health Records Dadong Li, Donna M Wolk, Michael N Cantor
78 [GO] 2020―Oct―01 Minor allele of Interferon-Induced Transmembrane Protein-3 (IFITM3) polymorphism (rs12252) is covered against SARS-CoV-2 infection and mortality: a worldwide epidemiological investigation Abhijit Pati, Sunali Padhi, Subham Suvankar, Aditya K Panda
79 [GO] 2020―Sep―26 Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study Andrea Pilotto, Stefano Masciocchi, Irene Volonghi, Massimo Crabbio, Eugenio Magni, Valeria De Giuli, et al. (+23)
80 [GO] 2020―Sep―16 No SARS-CoV-2 neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic Julia Schwaiger, Michael Karbiener, Claudia Aberham, Maria R Farcet, Thomas R Kreil
81 [GO] 2020―Sep―15 A granulocytic signature identifies COVID-19 and its severity Joana Vitte, Aïssatou Bailo Diallo, Asma Boumaza, Alexandre Lopez, Moïse Michel, Jérôme Allardet-Servent, et al. (+10)
82 [GO] 2020―Sep―09 Corrigendum to: COVID-19 Epidemic Doubling Time in the United States Before and During Stay-at-Home Restrictions Mark N Lurie, Joe Silva, Rachel R Yorlets, Jun Tao, Philip A Chan
83 [GO] 2020―Sep―09 Corrigendum to: Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship Takuya Yamagishi, Makoto Ohnishi, Nobuaki Matsunaga, Kensaku Kakimoto, Hajime Kamiya, Kiyoko Okamoto, et al. (+23)
84 [GO] 2020―Sep―08 Post-Mortem Findings in Italian Patients with COVID-19 - a Descriptive Full Autopsy Study of cases with and without co-morbidities Laura Falasca, Roberta Nardacci, Daniele Colombo, Eleonora Lalle, Antonino Di Caro, Emanuele Nicastri, et al. (+11)
85 [GO] 2020―Sep―08 SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors Sarah E Benner, Eshan U Patel, Oliver Laeyendecker, Andrew Pekosz, Kirsten Littlefield, Yolanda Eby, et al. (+19)
86 [GO] 2020―Sep―02 A study of universal SARS-CoV-2 RNA testing of residents and staff in a large group of care homes in South London Agnes Marossy, Stefan Rakowicz, Angela Bhan, Sarah Noon, Amanda Rees, Manjinder Virk, et al. (+5)
87 [GO] 2020―Sep―01 Immunosenescence and SARS-CoV-2 Vaccine Development David Nalin
88 [GO] 2020―Aug―04 Clinical and epidemiological features of 46 children under 1 year old with coronavirus disease 2019 (COVID-19) in Wuhan, China: a descriptive study Xinghua Liu, Rong Xie, Wei Li, Yan Guo, Bo Zhang, Yue Zhang, et al. (+8)
89 [GO] 2020―Aug―04 Factors associated with viral load kinetics of Middle East respiratory syndrome coronavirus during the 2015 outbreak in South Korea Jeong-Sun Yang, Min-Gyu Yoo, Hye-Ja Lee, Han Byul Jang, Hee-Dong Jung, Jeong-Gu Nam, et al. (+3)
90 [GO] 2020―Aug―04 Common human coronaviruses seem at least as severe as influenza in patients hospitalized with acute respiratory infection: results from 8-year hospital-based surveillance in Q, Canada Rodica Gilca, Sara Carazo, Rachid Amini, Hugues Charest, Gaston De Serres
91 [GO] 2020―Aug―04 SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence Gerco den Hartog, Rutger M Schepp, Marjan Kuijer, Corine GeurtsvanKessel, Josine van Beek, Nynke Rots, et al. (+3)
92 [GO] 2020―Aug―04 Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting Katherine Bond, Suellen Nicholson, Seok Ming Lim, Theo Karapanagiotidis, Eloise Williams, Douglas Johnson, et al. (+9)
93 [GO] 2020―Aug―01 Transient lymphopenia and interstitial pneumonia with endotheliitis in SARS-CoV-2-infected macaques Bon-Sang Koo, Hanseul Oh, Green Kim, Eun-Ha Hwang, Hoyin Jung, Youngjeon Lee, et al. (+4)
94 [GO] 2020―Jul―31 Prospective study comparing deep-throat saliva with other respiratory tract specimens in the diagnosis of novel coronavirus disease (COVID-19) Christopher K C Lai, Zigui Chen, Grace Lui, Lowell Ling, Timothy Li, Martin C S Wong, et al. (+9)
95 [GO] 2020―Jul―31 COVID-19 epidemic doubling time in the United States before and during stay-at-home restrictions Mark N Lurie, Joe Silva, Rachel R Yorlets, Jun Tao, Philip A Chan
96 [GO] 2020―Jul―31 Immunoserologic detection and diagnostic relevance of cross-reactive auto-antibodies in COVID-19 patients María Teresa Schiaffino, Marisa Di Natale, Elena García-Martínez, Joaquín Navarro, José Luis Muñoz-Blanco, Pablo Demelo-Rodríguez, Paloma Sánchez-Mateos
97 [GO] 2020―Jul―17 Environmental sampling for severe acute respiratory syndrome coronavirus 2 during COVID-19 outbreak in the Diamond Princess cruise ship Takuya Yamagishi, Makoto Ohnishi, Nobuaki Matsunaga, Kensaku Kakimoto, Hajime Kamiya, Kiyoko Okamoto, et al. (+23)
98 [GO] 2020―Jul―06 Direct observation of repeated infections with endemic coronaviruses Marta Galanti, Jeffrey Shaman
99 [GO] 2020―Jul―05 Overcoming Challenges in COVID-19 Translational Research Jonathan Z Li, Xu G Yu
100 [GO] 2020―Jun―28 The Definition and Risks of Cytokine Release Syndrome in 11 COVID-19-Affected Critically Ill Patients with Pneumonia: Analysis of Disease Characteristics Wenjun Wang, Xiaoqing Liu, Sipei Wu, Sibei Chen, Yimin Li, Lingbo Nong, et al. (+5)
101 [GO] 2020―Jun―26 Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study Ding Shi, Wenrui Wu, Qing Wang, Kaijin Xu, Jiaojiao Xie, Jingjing Wu, et al. (+7)
102 [GO] 2020―Jun―24 Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV Hsi-en Ho, Michael J Peluso, Colton Margus, Joao Pedro Matias Lopes, Chen He, Michael M Gaisa, et al. (+3)
103 [GO] 2020―Jun―23 Racial Disparity of Coronavirus Disease 2019 (COVID-19) in African American Communities Ravina Kullar, Jasmine R Marcelin, Talia H Swartz, Damani A Piggott, Raul Macias Gil, Trini A Mathew, Tina Tan
104 [GO] 2020―Jun―23 Group Testing for Sars-Cov-2 to Enable Rapid Scale-Up of Testing and Real-Time Surveillance of Incidence Christopher D Pilcher, Daniel Westreich, Michael G Hudgens
105 [GO] 2020―Jun―20 Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results Natalie N Kinloch, Gordon Ritchie, Chanson J Brumme, Winnie Dong, Weiyan Dong, Tanya Lawson, et al. (+8)
106 [GO] 2020―Jun―19 Serum Cytokine and Chemokine profile in Relation to the Severity of Coronavirus disease 2019 (COVID-19) in China Ying Chi, Yiyue Ge, Bin Wu, Wenshuai Zhang, Tao Wu, Tian Wen, et al. (+7)
107 [GO] 2020―Jun―16 Elevation of liver fibrosis index FIB-4 is associated with poor clinical outcomes in patients with COVID-19 Luis Ibáñez-Samaniego, Federico Bighelli, Clara Usón, Celia Caravaca, Carlos Fernández Carrillo, Miriam Romero, et al. (+9)
108 [GO] 2020―Jun―16 Ethical implementation of ‘immunity passports’ during the COVID-19 pandemic Teck Chuan Voo, Hannah Clapham, Clarence C Tam
109 [GO] 2020―Jun―16 Identifying capability framework that could mitigate the COVID-19 pandemic in global health community Martin C S Wong, Junjie Huang, Jeremy Y C Teoh, Sunny H Wong
110 [GO] 2020―Jun―16 Attenuated interferon and pro-inflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation Dong Yang, Hin Chu, Yuxin Hou, Yue Chai, Huiping Shuai, Andrew Chak-Yiu Lee, et al. (+11)
111 [GO] 2020―Jun―15 Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection Nicola Clementi, Roberto Ferrarese, Elena Criscuolo, Roberta Antonia Diotti, Matteo Castelli, Carolina Scagnolari, et al. (+4)
112 [GO] 2020―Jun―08 Airborne SARS-CoV-2 is Rapidly Inactivated by Simulated Sunlight Michael Schuit, Shanna Ratnesar-Shumate, Jason Yolitz, Gregory Williams, Wade Weaver, Brian Green, et al. (+13)
113 [GO] 2020―Jun―05 Corrigendum to: A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage Yuxia Cui, Maolu Tian, Dong Huang, Xike Wang, Yuying Huang, Li Fan, et al. (+13)
114 [GO] 2020―Jun―03 Estimating global epidemiology of low pathogenic human coronaviruses relating to the COVID-19 context Pengfei Li, Jiaye Liu, Zhongren Ma, Wichor M Bramer, Maikel P Pepelenbosch, Qiuwei Pan
115 [GO] 2020―Jun―03 SARS-CoV-2 Human Challenge Trials: Too Risky, Too Soon Liza Dawson, Jake Earl, Jeffrey Livezey
116 [GO] 2020―May―29 TPE-nAbs combination therapy for severe COVID-19 Miroslav Malkovsky
117 [GO] 2020―May―29 Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study Shaorui Hao, Jiangshan Lian, Yingfeng Lu, Hongyu Jia, Jianhua Hu, Guodong Yu, et al. (+17)
118 [GO] 2020―May―29 Multistate Outbreak of Seoul virus: Implications for the One Health Movement and Pandemic Preparedness Mary-Margaret A Fill
119 [GO] 2020―May―27 Performance of SARS-CoV-2 antibody assays in different stages of the infection: Comparison of commercial ELISA and rapid tests M Traugott, S W Aberle, J H Aberle, H Griebler, M Karolyi, E Pawelka, et al. (+3)
120 [GO] 2020―May―21 Transmission of SARS-CoV-2 via close contact and respiratory droplets among hACE2 mice Linlin Bao, Hong Gao, Wei Deng, Qi Lv, Haisheng Yu, Mingya Liu, et al. (+19)
121 [GO] 2020―May―20 Testing for Novel Covid-19 antibodies: a necessary adjunct Marco Daverio, Angela Amigoni, Maria Elena Cavicchiolo
122 [GO] 2020―May―19 Extended ORF8 Gene Region Is Valuable in the Epidemiological Investigation of SARS-similar Coronavirus Shuaiyin Chen, Xin Zheng, Jingyuan Zhu, Ronghua Ding, Yuefei Jin, Weiguo Zhang, et al. (+4)
123 [GO] 2020―May―16 Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients Peter D Burbelo, Francis X Riedo, Chihiro Morishima, Stephen Rawlings, Davey Smith, Sanchita Das, et al. (+4)
124 [GO] 2020―May―16 Influence of storage conditions on SARS-CoV-2 nucleic acid detection in throat swabs Lin Li, Xiao Li, Zhengdong Guo, Zhongyi Wang, Ke Zhang, Chao Li, et al. (+2)
125 [GO] 2020―May―06 T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19 Mei Jiang, Yang Guo, Qing Luo, ZiKun Huang, Rui Zhao, ShuYuan Liu, et al. (+3)
126 [GO] 2020―May―04 A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019 (COVID-19) Xue-fei Cai, Juan Chen, Jie-li Hu, Quan-xin Long, Hai-jun Deng, Kai Fan, et al. (+28)
127 [GO] 2020―May―04 Clinical characteristics of patients with COVID-19 in Japan: a single-center case series Ken-ichiro Kobayashi, Takahiro Kaki, Shinsuke Mizuno, Kenji Kubo, Nobuhiro Komiya, Satoko Otsu
128 [GO] 2020―Apr―30 Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development Kevin W Graepel, Sonali Kochhar, Ellen W Clayton, Kathryn E Edwards
129 [GO] 2020―Apr―28 Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19 Yonghong Zhang, Ling Qin, Yan Zhao, Ping Zhang, Bin Xu, Kang Li, et al. (+10)
130 [GO] 2020―Apr―28 Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19 Guoxin Zhang, Shuke Nie, Zhaohui Zhang, Zhentao Zhang
131 [GO] 2020―Apr―28 Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients Qing-Lei Zeng, Zu-Jiang Yu, Jian-Jun Gou, Guang-Ming Li, Shu-Huan Ma, Guo-Fan Zhang, et al. (+8)
132 [GO] 2020―Apr―23 COVID-19: Is Everything Appropriate to Create an Effective Vaccine? Andrea Cioffi
133 [GO] 2020―Apr―22 Epidemiological characteristics and incubation period of 7,015 confirmed cases with Coronavirus Disease 2019 outside Hubei Province in China Xiuquan Nie, Lieyang Fan, Ge Mu, Qiyou Tan, Mengyi Wang, Yujia Xie, et al. (+4)
134 [GO] 2020―Apr―21 Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China Xiao-Lin Jiang, Xiao-Li Zhang, Xiang-Na Zhao, Cun-Bao Li, Jie Lei, Zeng-Qiang Kou, et al. (+13)
135 [GO] 2020―Apr―21 Desperate times call for temperate measures: practicing infectious diseases during a novel pandemic Mark J Siedner, Rajesh T Gandhi, Arthur Y Kim
136 [GO] 2020―Apr―20 Epidemiological and clinical characteristics of 26 asymptomatic SARS-CoV-2 carriers Yanfeng Pan, Xue Yu, Xinwei Du, Qingqing Li, Xianyang Li, Tao Qin, et al. (+7)
137 [GO] 2020―Apr―15 Airborne or droplet precautions for health workers treating COVID-19? Prateek Bahl, Con Doolan, Charitha de Silva, Abrar Ahmad Chughtai, Lydia Bourouiba, C Raina MacIntyre
138 [GO] 2020―Apr―14 Epidemiology of seasonal coronaviruses: Establishing the context for COVID-19 emergence Sema Nickbakhsh, Antonia Ho, Diogo F P Marques, Jim McMenamin, Rory N Gunson, Pablo R Murcia
139 [GO] 2020―Apr―08 My Future in Medicine: How COVID-19 is Inspiring the Next Generation of Infectious Disease Specialists Jawara Allen
140 [GO] 2020―Apr―03 Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan Arnold S Monto, Peter DeJonge, Amy P Callear, Latifa A Bazzi, Skylar Capriola, Ryan E Malosh, et al. (+2)
141 [GO] 2020―Mar―31 Human challenge studies to accelerate coronavirus vaccine licensure Nir Eyal, Marc Lipsitch, Peter G Smith
142 [GO] 2020―Mar―28 Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia Fan Wang, Jiayan Nie, Haizhou Wang, Qiu Zhao, Yong Xiong, Liping Deng, et al. (+4)
143 [GO] 2020―Mar―14 Public health measures to slow community spread of COVID-19 Benjamin J Cowling, Allison Aiello
144 [GO] 2020―Feb―15 A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period Ping Yu, Jiang Zhu, Zhengdong Zhang, Yingjun Han


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.013 sec